Latest Placebo-controlled study Stories
A comparison of several international clinical trials of beta-blocker drugs has shown there are notable differences in how well the drugs prevent deaths in heart failure patients, based on where the patients were treated.
TARRYTOWN, N.Y., July 28, 2011 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced financial results for the second quarter of 2011 and provided an update on development programs and upcoming milestones.
Adrenaline has kept its place in cardiac arrest guidelines despite limited evidence for or against its use.
TOKYO, July 22, 2011 /PRNewswire/ -- Taiho Pharmaceutical Co., Ltd.
Placebos are often referred to as â€œdummy pillsâ€ in research trials for new drug therapies, but whether or not placebos can actually influence objective measures of disease has been unclear.
ROCKVILLE, Md., June 27, 2011 /PRNewswire/ -- Glycotex, Inc., a clinical stage biopharmaceutical company, announced today that it has submitted the final results of the two completed Phase II clinical studies of its drug product candidate, GLYC-101 gel, to the clinicaltrials.gov database.
SAN DIEGO, June 24, 2011 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announce Phase III study results for linagliptin, demonstrating improved glycemic control in adults with type 2 diabetes (T2D) whose blood sugar is not adequately controlled.
PRAGUE, Czech Republic, June 24, 2011 /PRNewswire/ -- The randomised, double-blind, placebo-controlled multi-centre study (abstract no.
EVANSTON, Ill., June 22, 2011 /PRNewswire/ -- Naurex Inc., a clinical-stage company developing innovative treatments to address unmet needs in psychiatry and neurology, today announced that it has initiated a Phase II clinical trial of its lead compound GLYX-13.
- The act of sweetening by admixture of some saccharine substance.